Flow Cytometry Crossmatch:A Sensitive Technique for assessment of acute rejection in renal transplantation (Articolo in rivista)

Type
Label
  • Flow Cytometry Crossmatch:A Sensitive Technique for assessment of acute rejection in renal transplantation (Articolo in rivista) (literal)
Anno
  • 1998-01-01T00:00:00+01:00 (literal)
Alternative label
  • A. Piazza, D. Adorno, E. Poggi, L. Borrelli, O. Buonomo, F. Pisani, M. Valeri, N. Torlone, C. Camplone, P.I. Monaco, D. Fraboni, and C.U. Casciani (1998)
    Flow Cytometry Crossmatch:A Sensitive Technique for assessment of acute rejection in renal transplantation
    in Transplantation proceedings; ELSEVIER, NEW YORK (Stati Uniti d'America)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • A. Piazza, D. Adorno, E. Poggi, L. Borrelli, O. Buonomo, F. Pisani, M. Valeri, N. Torlone, C. Camplone, P.I. Monaco, D. Fraboni, and C.U. Casciani (literal)
Pagina inizio
  • 1769 (literal)
Pagina fine
  • 1771 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 30 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
  • 3 (literal)
Note
  • PubMe (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • C.N.R. Institute of Tissue Typing, Unit of Rome; Department of Surgery, Tor Vergata University, Rome, Italy. (literal)
Titolo
  • Flow Cytometry Crossmatch:A Sensitive Technique for assessment of acute rejection in renal transplantation (literal)
Abstract
  • THE PRESENCE of anti- donor-specific antibodies before transplantation, detected using a complementdependent lymphocytotoxic test (CDC), is an absolute contraindication to renal transplant; moreover, some authors have observed a high incidence of acute rejection (ARj) episodes1-5 and a decreased graft survival6-9 in kidney transplant recipients with a positive flow cytometric crossmatch (FCXM) before transplantation. FCXM is more advantageous than CDC in that it shows a higher sensitivity in the detection of preformed antibodies10 and allows the simultaneous detection of complement-activating and nonactivating alloantibodies, the class of donor specific antibodies (IgG and/or IgM), and the donor target cells (T and/or B lymphocytes). Nevertheless, pretransplant crossmatching can only give an idea of presensitization. It is not able to identify all patients who will experience rejection following transplantation. Although needle core biopsy represents the most effective tool for diagnosing rejection, many efforts have been made to monitor rejection using less invasive procedures. The aim of this study was to demonstrate that among the many approaches used to monitor rejection in renal transplant recipients FCXM routinely performed after transplantation represents a specific, sensitive, and noninvasive method for monitoring donor specific immune responses. For this purpose FCXM was performed in the first 3 months after transplant on 42 patients who had received cadaveric kidney transplant. (literal)
Editore
Autore CNR
Insieme di parole chiave

Incoming links:


Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Editore di
Insieme di parole chiave di
data.CNR.it